EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Enteric Infections, Dysbiosis, and Metabolic Dysfunction: The Role of Diarrheagenic Pathogens in Insulin Resistance

Martin Zermeño-Ruiz iD, Filiberto Gutierrez-Gutierrez iD, Elsa Janneth Anaya-Ambriz iD, Emiliano Peña-Durán iD, Jesús Jonathan García-Galindo iD, Alfredo Huerta-Huerta, Araceli Lizbeth Quiñonez-Gallardo, Daniel Osmar Suárez-Rico iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27031610 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Martin Zermeño-Ruiz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Doctorado en Microbiología Médica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Mexico. Hauptthemen laut MEDLINE: Insulin Resistance, Dysbiosis, Diarrhea, Metabolic Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes and insulin resistance are increasingly recognized as conditions influenced not only by genetic and lifestyle factors but also by infectious and microbial exposures. Diarrheagenic pathogens, including enterotoxigenic, enteroaggregative, and enterohemorrhagic Escherichia coli, as well as other enteric microorganisms, disrupt the gut microbiota and compromise intestinal barrier integrity. These alterations promote dysbiosis, increased intestinal permeability, and systemic exposure to lipopolysaccharides and other microbial products, leading to metabolic endotoxemia and chronic low-grade inflammation. In parallel, pathogen-induced modulation of host immune responses contributes to adipose tissue inflammation, mitochondrial dysfunction, and impaired insulin signaling. This review summarizes current evidence linking diarrheagenic pathogens to insulin resistance, with emphasis on the microbiota–immune–metabolism axis. Understanding these interactions highlights novel perspectives on the pathogenesis of insulin resistance and suggests that targeted modulation of the gut microbiota or reduction in pathogen-driven inflammation may represent therapeutic opportunities to improve metabolic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceDysbiosisDiarrheaMetabolic DiseasesHumansAnimalsGastrointestinal MicrobiomeIntestinal Barrier FunctionInflammation

Stichwörter der Autor:innen

Clostridioides difficileEscherichia coliGiardia lambliaSalmonella entericachronic low-grade inflammationdiarrheagenic pathogensgut microbiotainsulin resistanceintestinal barrier dysfunctionnorovirusrotavirusshort-chain fatty acids (SCFAs)

Autor:innen und Institutionen

  • Doctorado en Microbiología Médica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Blvd. Marcelino García Barragán #1421, Guadalajara 44430, Mexico.
  • Departamento de Ciencias de la Salud, Centro Universitario de los Valles, Universidad de Guadalajara, Ameca 46708, Mexico.
  • Licenciatura en Médico Cirujano y Partero, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Departamento de Fisiología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Calle Sierra Mojada 950, Independencia Oriente, Guadalajara 44340, Mexico.
  • Institute of Experimental and Clinical Terapeutics (INTEC), Health Science University Center, Universidad de Guadalajara, Guadalajara 44340, Mexico.

ORCID-Profile: Martin Zermeño-Ruiz, Filiberto Gutierrez-Gutierrez, Elsa Janneth Anaya-Ambriz, Emiliano Peña-Durán, Jesús Jonathan García-Galindo, Daniel Osmar Suárez-Rico

Zitieren

APA

Zermeño-Ruiz, M., Gutierrez-Gutierrez, F., Anaya-Ambriz, E. J., Peña-Durán, E., García-Galindo, J. J., Huerta-Huerta, A., Quiñonez-Gallardo, A. L., & Suárez-Rico, D. O. (2026). Enteric Infections, Dysbiosis, and Metabolic Dysfunction: The Role of Diarrheagenic Pathogens in Insulin Resistance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031610

Vancouver

Zermeño-Ruiz M, Gutierrez-Gutierrez F, Anaya-Ambriz EJ, Peña-Durán E, García-Galindo JJ, Huerta-Huerta A, et al. Enteric Infections, Dysbiosis, and Metabolic Dysfunction: The Role of Diarrheagenic Pathogens in Insulin Resistance. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031610

BibTeX
@article{ZermeoRuiz2026,
  author = {Zermeño-Ruiz, Martin and Gutierrez-Gutierrez, Filiberto and Anaya-Ambriz, Elsa Janneth and Peña-Durán, Emiliano and García-Galindo, Jesús Jonathan and Huerta-Huerta, Alfredo and Quiñonez-Gallardo, Araceli Lizbeth and Suárez-Rico, Daniel Osmar},
  title = {Enteric Infections, Dysbiosis, and Metabolic Dysfunction: The Role of Diarrheagenic Pathogens in Insulin Resistance},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27031610}
}
Kostenlos starten →